Literature DB >> 26579681

Uromodulin, kidney function, cardiovascular disease, and mortality.

Olivier Devuyst1, Murielle Bochud2.   

Abstract

Uromodulin (Tamm-Horsfall protein) is exclusively produced by the kidney and is the most abundant protein excreted in normal urine. The level of uromodulin in urine could represent a useful biomarker for renal tubular function. The study of Garimella et al. adds elements into the debate, by suggesting that, in elderly adults, low urinary uromodulin concentrations in spot urine identify people at risk of progressive kidney disease and mortality above and beyond established markers of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26579681     DOI: 10.1038/ki.2015.267

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Martin G Larson; James B Meigs; Ramachandran S Vasan; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

Review 2.  The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease.

Authors:  Luca Rampoldi; Francesco Scolari; Antonio Amoroso; Gianmarco Ghiggeri; Olivier Devuyst
Journal:  Kidney Int       Date:  2011-06-08       Impact factor: 10.612

3.  Determination of uromodulin in human urine: influence of storage and processing.

Authors:  Sonia Youhanna; Julien Weber; Viviane Beaujean; Bob Glaudemans; Jens Sobek; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2013-10-03       Impact factor: 5.992

4.  Uromodulin levels associate with a common UMOD variant and risk for incident CKD.

Authors:  Anna Köttgen; Shih-Jen Hwang; Martin G Larson; Jennifer E Van Eyk; Qin Fu; Emelia J Benjamin; Abbas Dehghan; Nicole L Glazer; W H Linda Kao; Tamara B Harris; Vilmundur Gudnason; Michael G Shlipak; Qiong Yang; Josef Coresh; Daniel Levy; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

5.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

6.  Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis.

Authors:  Matthias Olden; Tanguy Corre; Caroline Hayward; Daniela Toniolo; Sheila Ulivi; Paolo Gasparini; Giorgio Pistis; Shih-Jen Hwang; Sven Bergmann; Harry Campbell; Massimiliano Cocca; Ilaria Gandin; Giorgia Girotto; Bob Glaudemans; Nicholas D Hastie; Johannes Loffing; Ozren Polasek; Luca Rampoldi; Igor Rudan; Cinzia Sala; Michela Traglia; Peter Vollenweider; Dragana Vuckovic; Sonia Youhanna; Julien Weber; Alan F Wright; Zoltán Kutalik; Murielle Bochud; Caroline S Fox; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

7.  Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.

Authors:  Pranav S Garimella; Mary L Biggs; Ronit Katz; Joachim H Ix; Michael R Bennett; Prasad Devarajan; Bryan R Kestenbaum; David S Siscovick; Majken K Jensen; Michael G Shlipak; Paulo H M Chaves; Mark J Sarnak
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

8.  Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.

Authors:  Olivier Devuyst; Luca Rampoldi; Matteo Trudu; Sylvie Janas; Chiara Lanzani; Huguette Debaix; Céline Schaeffer; Masami Ikehata; Lorena Citterio; Sylvie Demaretz; Francesco Trevisani; Giuseppe Ristagno; Bob Glaudemans; Kamel Laghmani; Giacomo Dell'Antonio; Johannes Loffing; Maria P Rastaldi; Paolo Manunta
Journal:  Nat Med       Date:  2013-11-03       Impact factor: 53.440

  8 in total
  7 in total

Review 1.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

2.  Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia.

Authors:  Yan Liu; David S Goldfarb; Tarek M El-Achkar; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

3.  Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine.

Authors:  Elisa Bellei; Stefania Bergamini; Cecilia Rustichelli; Emanuela Monari; Michele Dal Porto; Alessandro Fiorini; Aldo Tomasi; Anna Ferrari
Journal:  J Clin Med       Date:  2021-04-24       Impact factor: 4.241

4.  Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy.

Authors:  Olena Maydan; Paul G McDade; Yan Liu; Xue-Ru Wu; Douglas G Matsell; Allison A Eddy
Journal:  Physiol Rep       Date:  2018-03

5.  Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis.

Authors:  Shohei Tachibana; Masayuki Iyoda; Taihei Suzuki; Nobuhiro Kanazawa; Ken Iseri; Yukihiro Wada; Kei Matsumoto; Takanori Shibata
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

Review 6.  Urinary Protein and Peptide Markers in Chronic Kidney Disease.

Authors:  Natalia Chebotareva; Anatoliy Vinogradov; Valerie McDonnell; Natalia V Zakharova; Maria I Indeykina; Sergey Moiseev; Evgeny N Nikolaev; Alexey S Kononikhin
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

Review 7.  Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration.

Authors:  Alessandra Tammaro; Jesper Kers; Angelique M L Scantlebery; Sandrine Florquin
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.